CH625526A5 - - Google Patents

Download PDF

Info

Publication number
CH625526A5
CH625526A5 CH784176A CH784176A CH625526A5 CH 625526 A5 CH625526 A5 CH 625526A5 CH 784176 A CH784176 A CH 784176A CH 784176 A CH784176 A CH 784176A CH 625526 A5 CH625526 A5 CH 625526A5
Authority
CH
Switzerland
Prior art keywords
formula
group
alkyl
compound
acid
Prior art date
Application number
CH784176A
Other languages
German (de)
English (en)
Inventor
Michael Walter Foxton
Gordon Ian Gregory
David Malcolm Rogers
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of CH625526A5 publication Critical patent/CH625526A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH784176A 1975-06-19 1976-06-18 CH625526A5 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB26188/75A GB1555471A (en) 1975-06-19 1975-06-19 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof

Publications (1)

Publication Number Publication Date
CH625526A5 true CH625526A5 (ja) 1981-09-30

Family

ID=10239713

Family Applications (1)

Application Number Title Priority Date Filing Date
CH784176A CH625526A5 (ja) 1975-06-19 1976-06-18

Country Status (14)

Country Link
US (1) US4074047A (ja)
JP (1) JPS5214793A (ja)
AT (1) AT353956B (ja)
AU (1) AU505041B2 (ja)
BE (1) BE843152A (ja)
CH (1) CH625526A5 (ja)
DE (1) DE2627212A1 (ja)
DK (1) DK272676A (ja)
ES (1) ES449032A1 (ja)
FR (1) FR2315933A1 (ja)
GB (1) GB1555471A (ja)
NL (1) NL7606614A (ja)
SE (1) SE7607037L (ja)
ZA (1) ZA763635B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5517823B2 (ja) * 1972-05-16 1980-05-14
JPS4986668A (ja) * 1972-12-27 1974-08-20
US4175185A (en) * 1976-05-19 1979-11-20 Meiji Seika Kaisha Ltd. Process for preparing cephalosporanic acid derivatives
GB1591439A (en) * 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
GB1596278A (en) * 1976-11-30 1981-08-26 Glaxo Operations Ltd 7-(-oxyimino-acetamino)cephalosporin derivatives
US4208517A (en) * 1976-11-30 1980-06-17 Glaxo Operations Uk Limited Caphalosporin compounds having at position-7 an α-etherified hydroxyiminoarylacetamido group
NL7805715A (nl) * 1977-06-03 1978-12-05 Hoffmann La Roche Werkwijze voor het bereiden van acylderivaten.
EP0059486B1 (en) * 1978-07-17 1985-10-02 Fujisawa Pharmaceutical Co., Ltd. New starting compounds for preparing cephem compounds and processes for their preparation
FI782683A (fi) * 1978-07-19 1980-01-20 Hoffmann La Roche Kefalosporinestrar och -estrar
US4284631A (en) * 1978-07-31 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them
US4198504A (en) * 1978-11-02 1980-04-15 Bristol-Myers Company [3-(Pyridinium)-7-(naphthyiridinyl carbonylamino)acetamido]cephalosporanic acid derivatives
US4337376A (en) * 1979-12-31 1982-06-29 Broadcom, Incorporated Communications system and network
US7427680B2 (en) * 2001-01-12 2008-09-23 The Regents Of The University Of California Fluorogenic substrates for BETA-lactamase gene expression
EP1711504A2 (en) 2004-01-21 2006-10-18 Molecular Probes Inc. Derivatives of cephalosporin and clavulanic acid for detecting beta-lactamase in a sample
CN114478149B (zh) * 2022-01-18 2023-09-15 吉林化工学院 一种羧酸类化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1389194A (en) * 1971-01-29 1975-04-03 Glaxo Lab Ltd Antibiotics
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
GB1453049A (en) * 1973-08-21 1976-10-20 Glaxo Lab Ltd Cephalosporing antibiotics
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
DE2262500A1 (de) * 1972-12-20 1973-07-05 Lilly Co Eli 3-oxyiminomethylcephalosporinverbindungen
DK674674A (ja) * 1973-12-21 1975-09-08 Glaxo Lab Ltd

Also Published As

Publication number Publication date
AU1503276A (en) 1977-12-22
GB1555471A (en) 1979-11-14
AT353956B (de) 1979-12-10
DE2627212A1 (de) 1977-01-13
NL7606614A (nl) 1976-12-21
US4074047A (en) 1978-02-14
FR2315933B1 (ja) 1979-10-12
BE843152A (fr) 1976-12-20
ES449032A1 (es) 1977-11-16
DK272676A (da) 1976-12-20
SE7607037L (sv) 1976-12-20
FR2315933A1 (fr) 1977-01-28
AU505041B2 (en) 1979-11-08
ATA445876A (de) 1979-05-15
JPS5214793A (en) 1977-02-03
ZA763635B (en) 1977-05-25

Similar Documents

Publication Publication Date Title
DE2223375A1 (de) Antibiotika und Verfahren zu ihrer Herstellung
CH625526A5 (ja)
DE2744135A1 (de) Cephalosporinderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2204060A1 (de) Cephalosporin- und Penicillin-Antibiotika
DE2432415A1 (de) Antibiotica
DE2439880A1 (de) Antibiotika und verfahren zu ihrer herstellung
CH648851A5 (de) Cephalosporinantibiotika, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE2460537A1 (de) Cephalosporin-antibiotika
EP0009008A2 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
CH647784A5 (de) Cephalosporinantibiotika.
EP0163190A2 (de) Beta-Lactamantibiotika, Verfahren zu deren Herstellung sowie ihre Verwendung als Arzneimittel oder Wachstumsförderer in der Tieraufzucht oder als Antioxidantien
CH626370A5 (en) Process for the preparation of the syn isomer or of a mixture of syn and anti isomers of 7beta-acylamidoceph-3-em-4-carboxylic acids with antibiotic activity
US4385177A (en) Cephalosporins having a carbamoylalkoxyiminoarylacetamido group at 7-position
EP0000500B1 (de) Cephalosporinderivate, Verfahren zu deren Herstellung und deren pharmazeutische Präparate
EP0000392A2 (de) Cephalosporin und Penicillin-derivate, Verfahren zu deren Herstellung, und deren pharmazeutische Präparate
CH649557A5 (de) Cephalosporinantibiotika.
DE3011038A1 (de) Cephalosporinantibiotika
EP0035161B1 (de) Cephalosporine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2943437A1 (de) Cephalosporinverbindungen
DE3341591C2 (ja)
EP0054677B1 (de) Neue Cephalosporine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2818985C2 (de) Halogenarylmalonamidooxacephalosporine und deren Verwendung bei der Bekämpfung bakterieller Infektionen
AT362500B (de) Verfahren zur herstellung von neuen cephalos- porin-antibiotika
AT367061B (de) Verfahren zur herstellung von neuen antibiotischen verbindungen
EP0053276A2 (de) Neue Cephalosporine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased